Companies / BOC Sciences / Samalizumab
BOC Sciences

Samalizumab | BOC Sciences

(0) Write Review

Samalizumab is a humanized monoclonal antibody directed against the human immunosuppressive molecule CD200 (OX-2). Samalizumab has been used in the research of Multiple Myeloma and B-cell Chronic Lymphocytic Leukemia.

Reviews

(0) | Be the first to review this product
No reviews yet

ABOUT THE COMPANY

BOC Sciences
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
Scientific Products
  • See More
    • Upcoming Virtual Events
    Upcoming Webinars